Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report

Matsuura, Hiroaki; Higo, Hisao; Kuribayashi, Tadahiro; Tamaoki, Akihiko; Nakasuka, Takamasa; Uno, Mari; Makimoto, Go; Ninomiya, Kiichiro; Fujii, Masanori; Rai, Kammei; Ichihara, Eiki; Hotta, Katsuyuki; Miyahara, Nobuaki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki; Ohashi, Kadoaki

doi:10.1111/1759-7714.15324

Permalink : https://ousar.lib.okayama-u.ac.jp/67012

ID	67012
FullText URL	fulltext.pdf 1.55 MB
Author	Matsuura, Hiroaki Department of Respiratory Medicine, Okayama University Hospital Higo, Hisao Department of Respiratory Medicine, Okayama University Hospital Kuribayashi, Tadahiro Department of Respiratory Medicine, Okayama University Hospital Tamaoki, Akihiko Okayama Health Foundation Hospital, Okayama Health Foundation Nakasuka, Takamasa Department of Respiratory Medicine, Okayama University Hospital Uno, Mari Department of Respiratory Medicine, Okayama University Hospital Makimoto, Go Department of Respiratory Medicine, Okayama University Hospital Ninomiya, Kiichiro Department of Respiratory Medicine, Okayama University Hospital Kaken ID Fujii, Masanori Department of Respiratory Medicine, Okayama University Hospital Rai, Kammei Department of Respiratory Medicine, Okayama University Hospital Ichihara, Eiki Department of Respiratory Medicine, Okayama University Hospital Kaken ID publons Hotta, Katsuyuki Department of Respiratory Medicine, Okayama University Hospital Kaken ID publons researchmap Miyahara, Nobuaki Department of Respiratory Medicine, Okayama University Hospital Kaken ID publons researchmap Tabata, Masahiro Department of Respiratory Medicine, Okayama University Hospital Kaken ID researchmap Maeda, Yoshinobu Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap Kiura, Katsuyuki Department of Respiratory Medicine, Okayama University Hospital ORCID Kaken ID publons researchmap Ohashi, Kadoaki Department of Respiratory Medicine, Okayama University Hospital ORCID Kaken ID researchmap
Abstract	The concurrent incidence of lung cancer and tuberculosis is expected to escalate due to the projected growth in the older population. Combination therapy with osimertinib and antituberculosis drugs has not been well-established. We report a case of successful treatment involving the concomitant administration of osimertinib and antituberculosis drugs in an older patient, an 89-year-old female, diagnosed with epidermal growth factor receptor (EGFR)-mutant lung cancer and pulmonary tuberculosis. Accumulating evidence is warranted to develop an optimal treatment strategy for patients with lung cancer and tuberculosis.
Keywords	case report EGFR-mutated lung cancer osimertinib pulmonary tuberculosis rifampicin
Published Date	2024-05-02
Publication Title	Thoracic Cancer
Volume	volume15
Issue	issue17
Publisher	Wiley
Start Page	1390
End Page	1394
ISSN	1759-7706
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2024 The Authors.
File Version	publisher
PubMed ID	38698706
DOI	10.1111/1759-7714.15324
Web of Science KeyUT	001216948400001
Related Url	isVersionOf https://doi.org/10.1111/1759-7714.15324
License	https://creativecommons.org/licenses/by/4.0/
Citation	Matsuura H, Higo H, Kuribayashi T, Tamaoki A, Nakasuka T, Uno M, et al. Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report. Thorac Cancer. 2024; 15(17): 1390–1394. https://doi.org/10.1111/1759-7714.15324